NCT06418113 Neoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma Status RECRUITING Phase PHASE1
NCT06402708 Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3) Status RECRUITING Phase PHASE3
NCT06376604 Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies Status RECRUITING Phase NA
NCT06370663 First-line Treatment for Unresectable Locally Advanced Distal Cholangiocarcinoma Combining Radiotherapy and HAIC Status TERMINATED Phase PHASE2
NCT06353646 XH001 Combination With Immunocheckpoint Inhibitor and Chemotherapy for Patients With Resected Pancreatic Cancer Status RECRUITING Phase NA
NCT06353061 Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer Status RECRUITING Phase PHASE2
NCT06333314 Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI Status RECRUITING Phase PHASE2
NCT06306560 A Study of Adebrelimab Combined With Famitinib and Chemotherapy in the Treatment of ES-SCLC. Status NOT_YET_RECRUITING Phase PHASE2
NCT06304545 Treatment of Rectal Cancer With Long-term Concurrent Chemoradiotherapy Combined With Camrelizumab Status NOT_YET_RECRUITING Phase PHASE2
NCT06231680 Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP) Status RECRUITING Phase PHASE2
NCT06228326 A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs Status RECRUITING Phase PHASE1/PHASE2
NCT06223711 Durvalumab With Consolidative Radiochemotherapy and Ablative Stereotactic Radiotherapy in Oligometastatic ES-SCLC Status RECRUITING Phase PHASE2
NCT06196736 A Study to Evaluate 9MW2821 Versus Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer Status RECRUITING Phase PHASE3
NCT06195189 Sunvozertinib Combined With Chemotherapy for EGFRm After EGFR-TKI Treatment Failure:Phase I/II Status RECRUITING Phase PHASE1/PHASE2
NCT06186700 Effect of Pentoxifylline on Preventing Chemotherapy-induced Toxicities in Patients With Breast Cancer Status COMPLETED Phase PHASE2
NCT06152978 A Perioperative Sintilimab and Chemotherapy in Esophageal Squamous Cell Carcinoma Status NOT_YET_RECRUITING Phase PHASE2
NCT06121700 Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer Status RECRUITING Phase PHASE2
NCT06121505 Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Advanced or Metastatic Squamous Cell Lung Cancer Status RECRUITING Phase PHASE2